1.63% -0.0299

Bionano Genomics Inc (BNGO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BNGO Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Bionano Genomics Inc Stock (BNGO) Company Profile

Bionano Genomics Inc

Healthcare (1077)

(858) 888-7600

9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA

@bionanogenomics

Prossima data di guadagno

Ultimi documenti SEC

BNGO's Discussions on Twitter

Compare BNGO vs ISRG, BDX, RMD, ALC, MDLN

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BNGO Bionano Genomics Inc	1.8037	14.37M	28.74M	-31.60M	-19.30M	-5.0805
ISRG Intuitive Surgical Inc	399.64	130.41B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	181.71	48.44B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	224.58	31.49B	5.54B	1.52B	1.74B	10.37
ALC Alcon Inc	65.48	31.92B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	33.99	28.54B	29.14B	1.07B	1.05B	1.1956

Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-15	Downgrade	Ladenburg Thalmann	Buy → Neutral
2024-09-10	Downgrade	BTIG Research	Buy → Neutral
2023-01-05	Iniziato	Scotiabank	Sector Outperform
2022-12-12	Ripresa	BTIG Research	Buy
2022-07-18	Ripresa	Oppenheimer	Outperform
2021-06-16	Iniziato	BTIG Research	Buy
2020-09-24	Iniziato	Ladenburg Thalmann	Buy
2020-04-08	Iniziato	Oppenheimer	Outperform

Mostra tutto

Bionano Genomics Inc Borsa (BNGO) Ultime notizie

Bionano Genomics Inc Azioni (BNGO) Dati Finanziari

Bionano Genomics Inc Azioni (BNGO) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Luderer Albert	Interim Chief Executive	Aug 21 '26	Buy	1.22	4,000	4,860	4,000

Bionano Genomics Inc (BNGO)

Bionano Genomics Inc Stock (BNGO) Company Profile

Compare BNGO vs ISRG, BDX, RMD, ALC, MDLN

Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades

Bionano Genomics Inc Borsa (BNGO) Ultime notizie

Local Coverage Determinations Roundup: ChromaCode, Biofidelity, Biocartis, Bionano Genomics - GenomeWeb

MolDX proposes Medicare coverage for Bionano genome mapping test - Investing.com

MolDX proposes Medicare coverage for Bionano genome mapping test By Investing.com - Investing.com Canada

Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - The Manila Times

Bionano Genomics (BNGO) interim CEO adds 4,000 shares in IRA - Stock Titan

Bionano Laboratories Announces New York State Department of - GlobeNewswire

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Moomoo

Bionano Genomics (NASDAQ:BNGO) Shares Turns Active on Today’s Market Trigger - Kalkine Media

Bionano Genomics Inc. Warrant (BNGOW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Bionano Genomics Inc. Warrant (BNGOW) Peer Comparison – Compare with Others - Value Research

Bionano Genomics Inc. Warrant (BNGOW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

Bionano Genomics Inc. Warrant (BNGOW) Key Financial Ratios – Valuation, Profitability & More - Value Research

Bionano Genomics Inc. (BNGO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Bionano Genomics Inc. (BNGO) Peer Comparison – Compare with Others - Value Research

Bionano Genomics (NASDAQ: BNGO) interim CEO buys 4,000 shares - Stock Titan

Bionano (BNGO) Q2 2026 Results: EPS Exceeds Its Estimate at the Close; Latest Reaction: Shares Fall 0.84% in Latest TradingLong-Term Guidance - vinanet.vn

Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - qz.com

Bionano Genomics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - AOL.com

Alex Reid Hastie Net Worth (2026) - GuruFocus

Bionano Genomics (BNGO) investor discloses 9.9% position via warrants - Stock Titan

Gossamer Bio: Q2 Earnings Snapshot - AOL.com

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD) - The Globe and Mail

Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo

Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Bionano Reports Second Quarter 2026 Results and Provides a Business Update - Moomoo

Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Nigeria

Bionano Genomics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-08-11 - Seeking Alpha

Bionano Genomics Q2 2026 Earnings Call Transcript - MarketBeat

Bionano Genomics Q2 Results: Revenue rises 21% to $8.2 million - scanx.trade

Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus

Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... - Yahoo! Finance Canada

Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Bionano Genomics Q3 Results: Sales guidance ranges $8.200M-$8.600M - scanx.trade

BNGO Looks 21.6% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus

BIONANO GENOMICS ($BNGO) Releases Q2 2026 Earnings - Quiver Quantitative

How Could Bionano Genomics (NASDAQ:BNGO) Influence Penny Stocks Sentiment? - Kalkine Media

Bionano Genomics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

BNGO: Record Q2 revenue and margin driven by clinical adoption, with growth limited by supply constraints - TradingView

Is Bionano Genomics Inc (BNGO) Undervalued After Q2 Earnings? EPS: -$7.4M, Revenue: $8.2M, GF Score: 64/100 - GuruFocus

Transcript : Bionano Genomics, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com

Earnings call transcript: Bionano Genomics tops Q2 revenue view, shares edge up - Investing.com

Bionano Genomics raises FY26 sales guidance range - scanx.trade

Q2 2026 Bionano Genomics Inc Earnings Call Transcript - GuruFocus

Bionano Genomics Q2 revenue rises on increased clinical adoption - TradingView

BNGO: Q2 2026 revenue rose 21% but liquidity concerns threaten ongoing operations - TradingView

Bionano Reports Q2 2026 Revenue of $8.2M, Gross Margin 53% - TradingView

Bionano Genomics, Inc. Q2 2026: Revenue $8.17M, EPS $(0.64) — 10-Q Summary - TradingView

Bionano Genomics (NASDAQ: BNGO) grows revenue amid going concern warning - Stock Titan

BRIEF-Bionano Genomics Q2 Revenue USD 8.2 Million - TradingView

Bionano Genomics, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2026 - marketscreener.com

Bionano Genomics Inc Azioni (BNGO) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Bionano Genomics Inc Azioni (BNGO) insider trading

Simile a BNGO